Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines
- 1 November 1991
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (11) , 1194-1202
- https://doi.org/10.1016/0002-9149(91)90193-o
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiographyEuropean Heart Journal, 1991
- Congestive heart failure: Current controversies and future prospectsThe American Journal of Cardiology, 1990
- IbopamineDrugs, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Proarrhythmic responses during electrophysiologic testingThe American Journal of Cardiology, 1987
- Clinical types of proarrhythmic response to antiarrhythmic drugsThe American Journal of Cardiology, 1987
- Programmed electrical stimulation: Its role in the management of ventricular arrhythmias in coronary heart diseaseProgress in Cardiovascular Diseases, 1986
- The Dopamine Congener, Ibopamine, in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1984
- Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogramThe American Journal of Cardiology, 1984
- Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction.Circulation, 1981